Literature DB >> 4449006

The bioavailability of sixteen tetracycline products.

M C Meyer, R E Dann, P L Whyatt, G W Slywka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4449006     DOI: 10.1007/BF01061403

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  5 in total

1.  Cross-over study of ten tetracycline preparations.

Authors:  J Tuomisto; P Männistö
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

2.  Tetracycline inequivalence: the importance of 96-hour testing.

Authors:  C M Davis; J V Vandersarl; E W Kraus
Journal:  Am J Med Sci       Date:  1973-01       Impact factor: 2.378

3.  Improved fluorometric determination of tetracyclines.

Authors:  M Lever
Journal:  Biochem Med       Date:  1972-06

4.  Hazard of therapeutic nonequivalency of drug products.

Authors:  G H Schneller
Journal:  J Am Pharm Assoc       Date:  1969-09       Impact factor: 2.217

5.  Assessment of the biologic availability of tetracycline products in man.

Authors:  W H Barr; L M Gerbracht; K Letcher; M Plaut; N Strahl
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

  5 in total
  1 in total

1.  Dose-dependent bioavailability of tetracycline in man.

Authors:  J Adir; W H Barr
Journal:  J Pharmacokinet Biopharm       Date:  1978-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.